Ikarian Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Ikarian Capital's RCUS Position: Q3 2026 in Review
Ikarian Capital increased its Arcus Biosciences (RCUS) stake by 46% in Q3 2026, buying an estimated $6.48M and bringing the position to 734,559 shares worth $19M. The position accounts for 1.91% of the portfolio, ranked #9.
Ikarian Capital first reported a position in RCUS in Q4 2022 and has held it in 11 quarters since. 236 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Ikarian Capital held 734,559 shares of Arcus Biosciences worth $19M as of Q3 2026.
- Ikarian Capital bought 230,000 Arcus Biosciences shares in Q3 2026, an estimated $6.48M.
- Arcus Biosciences made up 1.91% of Ikarian Capital's portfolio in Q3 2026, its #9 holding.
- Ikarian Capital first reported a position in Arcus Biosciences in Q4 2022 and has held it in 11 quarters since.
- 236 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.